Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 5 | 2020 | 109 | 1.170 |
Why?
|
| Astrocytes | 4 | 2017 | 124 | 1.020 |
Why?
|
| HIV-1 | 5 | 2020 | 202 | 0.670 |
Why?
|
| HIV Infections | 4 | 2020 | 424 | 0.640 |
Why?
|
| AIDS Dementia Complex | 2 | 2017 | 39 | 0.560 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2015 | 50 | 0.560 |
Why?
|
| Wnt Proteins | 2 | 2014 | 20 | 0.540 |
Why?
|
| Theilovirus | 3 | 2012 | 3 | 0.520 |
Why?
|
| CD4 Antigens | 1 | 2015 | 29 | 0.480 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 29 | 0.460 |
Why?
|
| beta Catenin | 5 | 2017 | 55 | 0.440 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 517 | 0.440 |
Why?
|
| Demyelinating Diseases | 2 | 2011 | 12 | 0.430 |
Why?
|
| Multiple Sclerosis | 2 | 2012 | 77 | 0.400 |
Why?
|
| Membrane Proteins | 1 | 2014 | 151 | 0.400 |
Why?
|
| Mice | 8 | 2017 | 1236 | 0.340 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 30 | 0.340 |
Why?
|
| Cells, Cultured | 3 | 2015 | 481 | 0.310 |
Why?
|
| Brain | 1 | 2015 | 1200 | 0.280 |
Why?
|
| Animals | 8 | 2017 | 3287 | 0.270 |
Why?
|
| Signal Transduction | 3 | 2017 | 403 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 15 | 0.200 |
Why?
|
| Transcription Factors | 2 | 2014 | 149 | 0.180 |
Why?
|
| Mice, SCID | 3 | 2015 | 40 | 0.180 |
Why?
|
| Cardiovirus Infections | 2 | 2011 | 2 | 0.170 |
Why?
|
| Receptors, IgG | 1 | 2020 | 7 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 37 | 0.170 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 24 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2015 | 279 | 0.140 |
Why?
|
| Methamphetamine | 1 | 2017 | 22 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 39 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2020 | 104 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 89 | 0.120 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 5 | 0.120 |
Why?
|
| Heterografts | 1 | 2015 | 16 | 0.120 |
Why?
|
| Humans | 9 | 2020 | 23331 | 0.120 |
Why?
|
| CD8 Antigens | 1 | 2015 | 11 | 0.120 |
Why?
|
| Spleen | 1 | 2015 | 29 | 0.120 |
Why?
|
| Cell Movement | 1 | 2015 | 78 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 82 | 0.120 |
Why?
|
| Claudins | 1 | 2015 | 4 | 0.120 |
Why?
|
| Neurons | 1 | 2017 | 272 | 0.110 |
Why?
|
| HLA-DR Antigens | 1 | 2014 | 11 | 0.110 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 19 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 11 | 0.110 |
Why?
|
| HIV | 1 | 2014 | 39 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2014 | 74 | 0.110 |
Why?
|
| Acyltransferases | 1 | 2014 | 4 | 0.110 |
Why?
|
| Leukocytes | 1 | 2014 | 31 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2014 | 168 | 0.110 |
Why?
|
| Colon | 1 | 2015 | 110 | 0.110 |
Why?
|
| Fetus | 1 | 2014 | 31 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 34 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 23 | 0.110 |
Why?
|
| Virus Replication | 1 | 2014 | 41 | 0.100 |
Why?
|
| Monocytes | 1 | 2014 | 49 | 0.100 |
Why?
|
| Macrophages | 1 | 2014 | 98 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 360 | 0.100 |
Why?
|
| Immunologic Techniques | 1 | 2012 | 2 | 0.090 |
Why?
|
| Fas Ligand Protein | 1 | 2011 | 6 | 0.090 |
Why?
|
| Haplotypes | 1 | 2011 | 41 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 86 | 0.090 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2011 | 1 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 50 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 28 | 0.090 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2011 | 9 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 11 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2011 | 27 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 16 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 79 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2011 | 48 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 176 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2010 | 22 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 166 | 0.080 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 31 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 813 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 94 | 0.070 |
Why?
|
| Viral Load | 2 | 2020 | 69 | 0.060 |
Why?
|
| Transcription Factor 4 | 2 | 2014 | 8 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 246 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 188 | 0.040 |
Why?
|
| Cell Separation | 1 | 2020 | 21 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 49 | 0.040 |
Why?
|
| Male | 2 | 2017 | 12629 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 60 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 17 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2017 | 15 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 19 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 24 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 28 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 233 | 0.030 |
Why?
|
| Rats | 1 | 2017 | 625 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 230 | 0.030 |
Why?
|
| Female | 1 | 2011 | 13124 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 69 | 0.030 |
Why?
|
| Leukocyte Transfusion | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 9 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 14 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 20 | 0.030 |
Why?
|
| Vaccination | 1 | 2012 | 26 | 0.020 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 149 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 41 | 0.020 |
Why?
|
| Binding Sites | 1 | 2011 | 69 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 101 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 115 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 89 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 95 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 56 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 166 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 113 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 145 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2010 | 14 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 525 | 0.020 |
Why?
|